Epilepsy and the heart

While it is commonly known that epilepsy can cause loss of consciousness and disabling seizures, it is less well known that it can cause significant heart problems. A seizure can be potentially dangerous, triggering the nerves in the brainstem to increase blood pressure and heart rate and even cause dangerous heart rhythms. 
These cardiovascular effects are due to the mass activation of the autonomic nervous system, the sub-conscious automatic nerve network which controls breathing and circulation. 

The good news, as described in a recent publication in the highly-esteemed Journal of Neuroscience, is that our High Blood Pressure Group has been able to demonstrate the powerful cardio-protective properties of microglia, the brain's immune cells. 

The study found that by inhibiting microglia after a seizure, they were able to generate a significantly greater increase in sympathetic nerve activity, and subsequently more severe cardiovascular effects.  

In time, this means that we may be able to reduce the risk that an epileptic seizure will trigger a deadly heart attack.

These findings suggest that microglia are critical in soothing this increased excitation during seizures. 

Professor Paul Pilowsky, group leader of the High Blood Pressure Group, explains how this is achieved, “Microglia are able to soothe this overactivity by trimming the synaptic spines located on the dendrites of excited neurons.” 

“We are quite excited to have discovered that microglia perform a normal physiological role, in keeping excited cells in a state where they can respond effectively to further stimuli.” 

The study also found that a brain chemical called PACAP, which is released from neurons when they are active, is key to the communication process and works in concert with the microglia to dampen the sympathetic nerve response and protect the heart during seizures.

This deeper understanding of the role of microglia and PACAP during seizures adds to what is already known about the delicate interplay between the brain, heart and immune system in maintaining a healthy heart. 

Ultimately, these findings may lead to new therapies to prevent cardiovascular complications from epilepsy and other diseases which share an elevated sympathetic response, such as sleep apnoea and essential hypertension.


Related news

Gout Drug Mends Broken Hearts

A drug used to treat arthritis has been found to clear clogged arteries in heart attack survivors, world-first HRI research shows.

The landmark discovery by Associate Professor Sanjay Patel, Leader of the Cell Therapeutics Group, and his team at the HRI paves the way for a cheap, simple and effective treatment regime that could protect thousands of heart patients from future attacks that might kill them or further damage their heart. 

Read more

Stopping atherosclerosis in its tracks

A new treatment for atherosclerosis could soon be in sight, with an HRI study finding that progression of the common condition could be slowed using the chemokine binding protein ‘M3’.
Read more

Meet the team: Zohra Kakall

PhD student Zohra Kakall has always been fascinated by whole body physiology and the integration between the brain and other bodily systems. This fascination drew her to the HRI High Blood Pressure Group - which focuses on the way that brain networks control airways, breathing and blood pressure - and led her on a research trip across Europe.

Read more